Details for Patent: 9,474,746
✉ Email this page to a colleague
Which drugs does patent 9,474,746 protect, and when does it expire?
Patent 9,474,746 protects ACUVUE THERAVISION WITH KETOTIFEN and is included in one NDA.
This patent has twenty-one patent family members in twelve countries.
Summary for Patent: 9,474,746
| Title: | Methods for stabilizing oxidatively unstable compositions |
| Abstract: | Ophthalmic compositions and methods of preparing such compositions are disclosed. |
| Inventor(s): | Mahadevan; Shivkumar (Orange Park, FL), Molock; Frank (Orange Park, FL), Khanolkar; Vandeeta (Jacksonville, FL) |
| Assignee: | Johnson & Johnson Vision Care, Inc. (Jacksonville, FL) |
| Application Number: | 13/894,482 |
|
Patent Claim Types: see list of patent claims | Composition; Delivery; |
Drugs Protected by US Patent 9,474,746
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Johnson Johnson Visn | ACUVUE THERAVISION WITH KETOTIFEN | ketotifen fumarate | DRUG-ELUTING CONTACT LENS;OPHTHALMIC | 022388-001 | Feb 25, 2022 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,474,746
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 059927 | ⤷ Sign Up | |||
| Australia | 2007227091 | ⤷ Sign Up | |||
| Brazil | PI0709549 | ⤷ Sign Up | |||
| Canada | 2646424 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
